Madison Square Garden ENT

Forecast & Rating10 analysts currently cover Madison Square Garden ENT, with about 40.0% giving a positive rating — meaning they expect the stock to rise. The average price target is $91.63, about 15.1% upside from the current price of $79.59. Price targets span a fair range, indicating some disagreement among institutions. Historically, about 98.6% of past price targets were eventually met, which adds credibility. For you, this means institutional views on Madison Square Garden ENT are split — bulls and bears coexist, so you'll need to weigh it against your own judgment. Data as of Aug 20, 2026; for reference only and not investment advice.